ScholarWorks@SOONCHUNHYANG UNIVERSITY: Chang, Ah Ram

Detailed Information

Chang, Ah Ram (장아람)

College of Medicine (Department of Radiation Oncology)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

radiotherapy:7||Radiotherapy:4||hepatocellular carcinoma:3||Hepatocellular carcinoma:3||stereotactic body radiotherapy:3||Oligometastasis:2||Radiation oncology:2||Stereotactic body radiotherapy:2||Radiosurgery:2||Chemoradiotherapy:2||Prostate cancer:2||prostate cancer:2||esophageal squamous cell carcinoma:2||neutrophiltolymphocyte ratio:2||Consensus:1||CyberKnife:1||Deep learning:1||Distant metastasis:1||Dosevolume histogram:1||Extrahepatic bile duct cancer:1||Fiducial marker:1||Fractionated interval radiotherapy:1||Gastrointestinal toxicity:1||Gynecological:1||Highdose stereotactic radiotherapy:1||IGRT:1||Imagingguided radiation therapy:1||Interobserver variation:1||Kinetics:1||Korea:1||Locoregional recurrence:1||Lung tumor:1||NCCN:1||Neutrophil to lymphocyte ratio:1||Nomogram:1||Normoxic polymethacrylic acid gel:1||PSA:1||Patterns of care:1||Perihilar extrahepatic cholangiocarcinoma:1||Platelet to lymphocyte ratio:1||Prognosis:1||Prognostic factor:1||RTQA:1||Radiation:1||Radiation oncologists:1||Rib fracture:1||Risk factors:1||SABR:1||SBRT:1||Small field beam:1||Spinal metastases:1||Stereotactic:1||Stereotactic ablative radiotherapy:1||Survey:1||Surveys and questionnaires:1||Ultrasonography:1||Ultrasound:1||Xray CT:1||abscopal effect:1||adaptive radiotherapy:1||adjuvant chemotherapy:1||anal cancer:1||bladder cancer:1||breast cancer:1||deformable image registration:1||doseescalation:1||dummy run:1||endoscopy:1||hepatocellular:1||hypofractionation:1||image quality:1||inflammation:1||interventional:1||lens:1||local therapy:1||lung cancer:1||megavoltage computed tomography (MVCT):1||metastasis:1||metformin:1||multicenter trial:1||multiple scan average dose (MSAD):1||oligometastasis:1||pathologic difference:1||pattern of failure:1||photoluminescence glass dosimeters (PLDs):1||prognostic factor:1||prostatectomy:1||prostatic neoplasms:1||quality assurance:1||radiation response:1||radiation therapy:1||radiotherapy dose escalation:1||recurrence:1||risk assessment:1||stereotactic radiotherapy:1||survey:1||survey study:1||survival:1||toxicity:1||3D couplant:1||treatment outcome:1||3D printing:1||4D dose calculation:1||Anal cancer:1||Autocontouring:1||Brain metastasis:1||Breast cancer:1||CT contrast:1||CT scanning parameters:1||Carcinoma:1||Chest wall toxicity:1||Clinical target volume:1||Colorectal neoplasms:1||Colorectal surgeon:1||

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE